Aarti Shah
About Aarti Shah
Aarti Shah (age 60) has served as an independent director of NVIDIA since 2020. She spent 27.5 years at Eli Lilly, culminating as SVP & Chief Information and Digital Officer; her technical background spans applied statistics, data science, cybersecurity, and digital health, with a PhD in Applied Statistics (UC Riverside) and BS/MS in Statistics & Mathematics (India) . On NVIDIA’s Board, she brings senior leadership, industry/technical expertise, governance experience, and risk/legal awareness per the skills matrix .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Eli Lilly and Company | Senior Vice President & Chief Information and Digital Officer; previously Senior Statistician, Research Scientist, VP Biometrics, Global Brand Development Leader (Bio-Medicines) | 27.5 years; through 2021 | Led IT/digital, analytics, cyber/data platforms; drug development expertise |
External Roles
| Organization | Role | Since/Through | Committees/Notes |
|---|---|---|---|
| Sandoz International GmbH | Director | Since 2023 | Science, Innovation & Development; Human Capital & ESG committees |
| Northwestern Mutual | Board of Trustees | Since 2020 | Audit Committee; Distribution & Technology Committee |
| St. Jude Children’s Research Hospital & ALSAC | Board member | Current | Strategic Planning; Global & Technology committees |
| Shrimad Rajchandra Mission Dharampur USA | Trustee | Current | Non-profit trustee |
| Prior non-profits | Indianapolis Public Library Foundation; Center for Interfaith Cooperation | Completed full terms | Governance/oversight roles |
Board Governance
| Item | Detail |
|---|---|
| Independence | Board determined all directors except CEO are independent; all AC/CC/NCGC members are independent (Shah serves on AC and CC) . |
| Committees (until/after 2025 Mtg) | Audit Committee (AC); Compensation Committee (CC) – continues post-meeting . |
| Committee meetings (FY2025) | AC met 4 times; CC met 4 times; NCGC met 3 times . |
| Attendance | Each Board member attended ≥75% of Board/committee meetings in FY2025; directors expected to attend annual meeting; independent directors held executive sessions at 4 quarterly meetings . |
| Lead Independent Director | Stephen C. Neal; robust duties and stockholder engagement . |
| Director time/boards | None of NVIDIA directors serve on >2 public company boards (including NVIDIA) . |
| Skills (matrix) | Senior leadership; industry/technical; governance; emerging tech; marketing/brand; regulatory/legal/risk; human capital . |
Fixed Compensation
| Component | FY2025 Amount/Terms |
|---|---|
| Annual cash retainer | $85,000 (non-employee director) . |
| Committee/Chair/Meeting fees | None – NVIDIA does not pay additional fees for committee service/chair or meeting attendance . |
| Total target (program design) | 2024–2025 Director Program target total value $340,000 (cash + equity) . |
| Other benefits | Expense reimbursement; no CIC benefits for directors except acceleration if awards not assumed; death accelerates vesting . |
Performance Compensation
| Equity Element | Grant/Value | Vesting | Notes |
|---|---|---|---|
| Annual RSU (2024 Program) | 2,088 shares granted 6/27/2024; ASC 718 grant-date FV $123.96/share (per-director $258,828) | 50% vested 3rd Wed Nov 2024; 50% vests 3rd Wed May 2025 (service-based) | No dividends on unvested or vested-but-deferred RSUs; directors may defer settlement (409A) . |
| Aarti Shah – RSUs outstanding (1/26/2025) | 1,044 unvested RSUs | Per program schedule | Service-based; not performance-conditioned |
Performance metrics: NVIDIA’s director equity is time-based RSUs; no PSU or performance metrics apply to non-employee directors (aligns via stock price exposure) .
Other Directorships & Interlocks
| Company/Org | Public Company? | Interlocks/Notes |
|---|---|---|
| Sandoz International GmbH | Listed as “Other Current Public Company Board” in proxy | Pharma; no disclosed NVIDIA-related transactions . |
| Compensation Committee interlocks | N/A | NVIDIA reports no executive interlocks; notes that other than Dr. Shah, no CC member had a relationship requiring disclosure—see related-party item below . |
Expertise & Qualifications
| Area | Evidence |
|---|---|
| Technical/AI/Cyber/Data | IT, cybersecurity, advanced analytics, data sciences leadership at Eli Lilly . |
| Governance & public boards | Roles at Sandoz and Northwestern Mutual; multiple non-profit boards . |
| Education | PhD Applied Statistics (UC Riverside); BS/MS Statistics & Mathematics (India) . |
| Human capital/ESG | Committees at Sandoz (Human Capital & ESG) and St. Jude/ALSAC . |
Equity Ownership
| Measure | Amount |
|---|---|
| Shares beneficially owned (3/24/2025) | 13,200 shares . |
| Vested RSUs deferred (not included above) | 38,964 shares deferred for future issuance . |
| Unvested RSUs (1/26/2025) | 1,044 RSUs . |
| Ownership guidelines | Directors must hold ≥6x annual cash retainer; 5 years to comply; all non-employee directors meet/exceed (except Ochoa, new in 2024) . |
| Hedging/pledging | Prohibited: no hedging, pledging, margin accounts, or derivatives in NVIDIA stock . |
Director Compensation (FY2025)
| Component | Cash ($) | Stock Awards ($) | Total ($) |
|---|---|---|---|
| Aarti Shah | 85,000 | 258,828 (2,088 RSUs at $123.96/share) | 343,828 |
Insider Trades
| Item | Detail |
|---|---|
| Section 16 compliance | Company reports all required filings complied with for FY2025, except two Form 4s for a different director (Drell); no delinquencies noted for Shah . |
| Form 4 transactions | Not detailed in proxy; refer to Section 16 filings for any post-period transactions (not provided in this document) . |
Related-Party and Conflict Review
- RED FLAG: Dr. Shah’s son has been employed by NVIDIA since Feb 2024 with FY2025 total compensation of approximately $475,000; NVIDIA states compensation was set per standard practices without Dr. Shah’s involvement . Dr. Shah served on the Compensation Committee during FY2025; proxy explicitly notes “Other than Dr. Shah” in flagging CC members with relationships requiring disclosure, elevating perceived conflict risk despite independence status .
- Related-party approval: NCGC approves related-party transactions under policy; Board maintains independence determination for Shah .
Governance Assessment
- Strengths:
- Independent director with deep data/cyber/IT expertise; serves on Audit and Compensation—committees central to financial integrity and pay governance .
- Solid engagement/attendance profile; Board/committees met regularly; each director ≥75% attendance; robust executive sessions .
- Ownership alignment: meaningful ownership plus deferred RSUs; complies with 6x retainer guideline; hedging/pledging prohibited .
- Director pay structure is straightforward (cash retainer + time-based RSUs), no meeting/committee fees that could distort incentives .
- Risk indicators:
- RED FLAG: Immediate family employment within the company while serving on CC raises perceived conflict risk; disclosure and committee oversight mitigate but investors may scrutinize CC decisions where conflicts could arise .
- External board load appears reasonable (≤2 public boards), lowering overboarding risk .
Overall, Shah’s technical depth and committee roles support Board effectiveness in areas material to NVIDIA (cybersecurity, data, and human capital), with one notable related-party exposure requiring continued monitoring for potential conflicts and recusals on any directly implicated matters .